| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/20/2008 | US20080070281 Method for Stabilising Reagents Which are Useful for Nucleic Acid Amplification |
| 03/20/2008 | US20080070273 Culturing marine bacteria and isolating viricidal, bactericididal, fungicidal and antitumor agents from broths |
| 03/20/2008 | US20080070272 Bioanalysis kits |
| 03/20/2008 | US20080070271 Function homology screening |
| 03/20/2008 | US20080070270 Using nutrient matrix comprising cancerous tissue as tool in screening and identifying antiproliferative agents |
| 03/20/2008 | US20080070269 Three-dimensional physiological matrices for oncological testing, and methods for their production and use |
| 03/20/2008 | US20080070268 Differential expression profiling analysis of cell culture phenotypes and the uses thereof |
| 03/20/2008 | US20080070267 changing the pattern of Ca2+ spike activity of the neuron; treating psychological disorder using electrical or chemical stimulants, or antagonist; altering neurotransmitter expression; autism, anxiety disorder, post-traumatic stress disorder, depression, bipolar disorder and schizophrenia |
| 03/20/2008 | US20080070266 Bioassay for monitoring caspase-3 mediated cell death |
| 03/20/2008 | US20080070265 Using immunoglobulins specific to apolipoproteins as diagnostic tool in detection of cardiovascular disorders |
| 03/20/2008 | US20080070264 Using glial cell line derived neurotrophic factor receptor as tool in identifying modulator for prevention and treatment of cell proliferative disorders |
| 03/20/2008 | US20080070260 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/20/2008 | US20080070257 Using fluorescence resonance energy transfer and reconstituted nucleosomes as tools in identifying compounds which modify enzyme activity; immunoassay |
| 03/20/2008 | US20080070256 Non-Human Animal Models for B-cell Non-Hodgkin's Lymphoma and Uses Thereof |
| 03/20/2008 | US20080070255 Novel gene and uses therefor to modify pasture qualities of crops |
| 03/20/2008 | US20080070254 Using presence of brittle regions (fragile site 12E) within silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene as diagnostic indicator of tumor progression |
| 03/20/2008 | US20080070253 Methods and products for in vitro genotyping |
| 03/20/2008 | US20080070252 CHR and POMC effects on animal growth |
| 03/20/2008 | US20080070251 Method of Producing Factor VIII Proteins by Recombinant Methods |
| 03/20/2008 | US20080070250 Method of removing air bubbles from hybridization solution of microarray-coverslip assembly and microarray kit for the same |
| 03/20/2008 | US20080070249 Peroxisome proliferator activator gamma coactivator-1 alpha (PGC-1 alpha ) for use as modulator of glucose transport; antidiabetic agents |
| 03/20/2008 | US20080070248 Using allelic variation to predict response of individuals to growth hormone receptor (GHR) modulators; treating obesity and acromegaly |
| 03/20/2008 | US20080070247 Physiogenomic method for predicting effects of exercise |
| 03/20/2008 | US20080070246 Recombinant protein and method of screening for agents that modulate polypeptide aggregation |
| 03/20/2008 | US20080070245 Method for herd management of domestic ruminants to control infection due to mycobacterium avium subspecies paratuberculosis |
| 03/20/2008 | US20080070244 Apparatus for determining presence or absence of airborne fungal spores in multiple locations within a structure |
| 03/20/2008 | US20080070243 Using RNA expression patterns as diagnostic tool in detection of infection and inflammatory disorders |
| 03/20/2008 | US20080070242 Using mutation in hyaluronan synthase-1 (HAS1) gene as indicator tool in diagnosis/prognosis of cell proliferative disorders |
| 03/20/2008 | US20080070241 Kits for amplifying and detecting nucleic acid sequences |
| 03/20/2008 | US20080070240 Composition for deaminating dna and method of detecting methylated dna |
| 03/20/2008 | US20080070239 Using concentration of calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) as diagnostic indicators for bladder, bowel and/or reproductive tissue/organ disorders |
| 03/20/2008 | US20080070238 Method for the Synthesizing Nucleic Acids, and Application Thereof |
| 03/20/2008 | US20080070237 Npas3 Mutant Mice and Uses for Screening and Testing Therapies for Schizophrenia and Related Neurological Disorders |
| 03/20/2008 | US20080070236 Method for Sequencing Nucleic Acid Molecules |
| 03/20/2008 | US20080070235 Using systemic inflammatory response syndrome (SIRS) gene sequences as probes in detecting microorganismal infection |
| 03/20/2008 | US20080070234 Measuring Range Extension of Chromatographic Rapid Tests |
| 03/20/2008 | US20080070233 Quantitative analysis and typing of subcellular particles |
| 03/20/2008 | US20080070232 Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression |
| 03/20/2008 | US20080070231 Genetically engineered biological indicator |
| 03/20/2008 | US20080069838 Novel human virus causing severe acute respiratory syndrome (sars) and uses thereof |
| 03/20/2008 | US20080069827 miRNA of HSV-LAT and uses thereof |
| 03/20/2008 | US20080069822 Immunoglobulins; cell line; screening; side effect reduction |
| 03/20/2008 | US20080069819 Method and composition for detecting cancer by means of detection of epstein-barr virus nuclear antigen 2 coactivator p100 |
| 03/20/2008 | US20080069818 Method of Increasing Efficacy of Tumor Cell Killing Using Combinations of Anti-Neoplastic Agents |
| 03/20/2008 | US20080069812 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 03/20/2008 | US20080069811 Follicle stimulating hormone (Fsh); bioavailability; drug screening |
| 03/20/2008 | US20080069809 Administering ingenol angelate to treat cancer cells having high protein kinase C (PKC) activity; myeloid leukiemia |
| 03/20/2008 | US20080069806 Method of screening for substances useful for transdifferentiation of microglia into neurons |
| 03/20/2008 | US20080069772 Treatment of transformed or infected biological cells |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | US20080069734 Suspending an emissive small organic molecule or an emissive conjugated polymer in a compressed carbon diioxide solvent phase, depositing the suspension onto the desired layer of light emitting diode, evaporating the solvent; uses a cheap, environmentally friendly solvent |
| 03/20/2008 | DE102006041644A1 Detecting modifications in a protein or peptide comprises treating a sample with a cleavage-site-specific protease to produce a mixture of peptide fragments and analyzing the mixture |
| 03/20/2008 | DE102006041455A1 Verfahren zur Verbesserung der spezifischen Effektorfunktion von Einzelketten-Antigen-erkennenden genetischen Konstrukten (scARC) durch deren Murinisierung A method for improving the effector function of specific single-chain antigen-recognizing genetic constructs (scARC) through their murinization |
| 03/20/2008 | CA2842966A1 Cell culture improvements |
| 03/20/2008 | CA2680436A1 Methods of using sip-10 to assess hcv clearance and/or response to interferon therapy |
| 03/20/2008 | CA2672921A1 Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes |
| 03/20/2008 | CA2666819A1 Mammalian oocyte development competency granulosa markers and uses thereof |
| 03/20/2008 | CA2664043A1 Use of taq polymerase mutant enzymes for dna amplification in the presence of pcr inhibitors |
| 03/20/2008 | CA2663442A1 Cell culture improvements |
| 03/20/2008 | CA2663286A1 Automated fish analysis, circulating microfluidic chip, and method for immobilizing cells to a microfluidic chip |
| 03/20/2008 | CA2663045A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | CA2662547A1 Genomic marker for meat tenderness |
| 03/20/2008 | CA2662236A1 Methods and compositions for the diagnosis and treatment of cancer |
| 03/20/2008 | CA2660853A1 Control system for uv lamps, and check system for determining the viability of microorganisms |
| 03/19/2008 | EP1901074A1 Adam12 as marker for fetal Turner Syndrome |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1901064A2 Method for measuring skin absorbability |
| 03/19/2008 | EP1900827A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia |
| 03/19/2008 | EP1900826A1 Genomic marker for tenderness meat |
| 03/19/2008 | EP1900825A1 Sensitive and reproducible method for the determination of MGMT promoter methylation in clinical samples |
| 03/19/2008 | EP1900824A1 Gene expression signature for the prognosis, diagnosis and therapy of prostate cancer and uses thereof |
| 03/19/2008 | EP1900823A2 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 03/19/2008 | EP1900822A1 Method for simultaneous analysis of multiple bioilogical reactions or changes in in vivo conditions |
| 03/19/2008 | EP1900818A2 Neisserial antigens |
| 03/19/2008 | EP1900817A1 A bentazon and sulfonylurea herbicide-resistant gene cyp81a6 of rice |
| 03/19/2008 | EP1900813A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 03/19/2008 | EP1900811A1 Enriched central nervous system cell populations |
| 03/19/2008 | EP1900749A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/19/2008 | EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899860A1 Method of processing and/or genome mapping of ditag sequences |
| 03/19/2008 | EP1899727A1 Probe-immobilized carrier storing manufacturing condition data and manufacturing method and apparatus thereof, detecting method of target substance by use of the probe-immobilized carrier, and measuring apparatus, recording medium, kit and system for use in the detecting method |
| 03/19/2008 | EP1899725A1 Nucleic acid biosensor with photoelectrochemical amplification |
| 03/19/2008 | EP1899488A2 Chromosome conformation capture-on-chip (4c) assay |
| 03/19/2008 | EP1899487A2 Gfats as modifiers of the axin pathway and methods of use |
| 03/19/2008 | EP1899486A2 Methods for the identification, assessment, and treatment of patients with cancer therapy |
| 03/19/2008 | EP1899485A1 Method for fixing a supercoiled dna and the use for analysing the dna repair |
| 03/19/2008 | EP1899484A2 Identification of tumors and tissues |
| 03/19/2008 | EP1899482A2 Ddr2 in cancer diagnosis, detection and treatment |
| 03/19/2008 | EP1899481A1 Classification method |
| 03/19/2008 | EP1899480A1 Compositions and methods for treating inflammatory conditions |
| 03/19/2008 | EP1899048A1 Low wetting hysteresis hydrophobic surface coating, method for depositing same, microcomponent and use |
| 03/19/2008 | EP1898803A2 Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| 03/19/2008 | EP1898729A2 Compositions comprising and processes for producing inorganic salts of hop acids |
| 03/19/2008 | EP1815226A4 Device and method for purification of biological materials |
| 03/19/2008 | EP1778864A4 Capture probe design for efficient hybridisation |
| 03/19/2008 | EP1738167A4 Method of diagnosing the chances of pregnancy and the diagnostic kit for the same |
| 03/19/2008 | EP1725216A4 Immunoliposome-nucleic acid amplication (ilnaa) assay |